<DOC>
	<DOCNO>NCT00462254</DOCNO>
	<brief_summary>Patients Parkinson 's disease represent significant proportion VA elderly patient . Sleep disturbance caregiver burnout association condition represent significant problem . In study , investigator propose perform evaluation fix doe ramelteon sleep VA outpatient diagnose Parkinson 's disease . The hypothesis examine ramelteon improve quality sleep patient Parkinson 's disease indirectly improve quality life patient caregiver . The investigator hypothesize change occur restructure normalization sleep architecture .</brief_summary>
	<brief_title>Ramelteon ( ROZEREM ) Treatment Sleep Disturbances Associated With Parkinson 's Disease</brief_title>
	<detailed_description>It well establish sleep disturbance common patient neurodegenerative disorder Parkinson 's disease . Together psychosis behavioral abnormality contribute stress , anxiety cognitive decline patient , caregiver burnout depression , well health care provider frustration . The mechanisms sleep disturbance condition still poorly understood rational effective treatment propose . Recent data study ramelteon elderly show striking ability compound improve quality sleep disturbance Parkinson 's disease . Objectives study : - To examine effect ramelteon quality sleep use sleep evaluation instrument ( SDQ-Sleep Disorder Questionnaire Neuropsychiatric Inventory Caregiver Distress ( NPI-D ) Sleep Behavior Subscale administer patient and/or bed partner . - To examine effect ramelteon daytime sleepiness memory use Epworth Sleepiness Scale ( ESS ) Hopkins Verbal Learning Test ( HVLT ) . - To examine effect ramelteon sleep/wake cycle day/night activity pattern prolong period time ( 1 week ) use motion logger ( continuous motor activity record device ) computerize data analysis . - To examine effect ramelteon sleep architecture sample patient confirm sleep disturbance , ramelteon treatment use polysomnography .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Dyssomnias</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<criteria>4585 year age live community Male female nonchild bearing potential ( nonchild bearing define lease 6 month postmenopause surgically sterile ) Must diagnosis Parkinson 's disease Must complaint sleep disturbance Patients diagnosis meeting DSMIV criterion major depression , schizophrenia schizoaffective disorder , bipolar disorder , substance abuse disorder , mental illness know contribute sleep disturbance , epilepsy , medical condition know cause contribute sleep disturbance Patients currently use melatonin ramelteon , hypnotic , benzodiazepine , antidepressant , bloodbrain barrier permeable beta blocker , steroid , antipsychotic Patients clinically significant blood urine abnormality Patients take investigational drug le 1 month prior baseline visit Patients multiple concomitant disorder without medication think produce sleep disturbance Patients preexist sleep disturbance unrelated Parkinson 's disease Patients severe hepatic impairment ( ChildPugh Class C ) Patients severe COPD ( elevate pCO2 level need nocturnal oxygen therapy Patients severe sleep apnea Patients sensitivity ramelteon constituent Rozerem preparation Patients take rifampin potent inducer CYP1A2 , CYP3A4 , CYP2C9 ( ketoconazole , fluconazole ) Patients live nurse home . Those live assist live facility board care facility may include Patients unable comply study protocol</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Ramelteon</keyword>
	<keyword>Parkinson 's disease</keyword>
	<keyword>Sleep disturbance</keyword>
</DOC>